Table 1.
Overview of immunohistochemistry and molecular findings at different pathology institutes
| Local pathology | Tertiary referral center | US institution | German institution | |
|---|---|---|---|---|
| Diagnosis | − | MBC | central type of PNET | EFT |
| CD99 | positive | positive | positive | positive |
| Vimentin | positive | positive | − | positive |
| Cytokeratin 7, cytokeratin 20 | positive | − | − | − |
| Cytokeratin AE1/AE3 | positive | positive | positive | positive |
| Synaptophysin | − | − | positive | positive |
| CD56 | − | − | positive | − |
| Chromogranin A | negative | − | − | positive (single cells) |
| WT1 | negative | − | − | negative |
| CA15-3, TTF1, β-hCG, CD10 | negative | − | − | − |
| Estrogen, progesterone receptors | negative | negative | − | − |
| S-100 | − | − | negative | negative |
| Desmin | − | − | negative | negative |
| GFAP | − | − | negative | − |
| CK5/14, smooth muscle actin, myogenin, 34βΕ12, | ||||
| MPO, CD20, CD3 | − | − | − | negative |
| t(11;22) | − | negative | − | negative |
| t(21;22) | − | negative | − | negative |
| t(18;X), i(12)p | − | negative | − | − |
EFT, Ewing family tumors; MBC, metaplastic breast cancer; PNET, primitive neuroectodermal tumor.